Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

83%

5 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
5(100.0%)
5Total
Phase 4(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07294820Recruiting

The Use of a Fully Digital Workflow in Immediate Implants With Immediate Restoration

Role: lead

NCT02023840Phase 4Completed

The Use of Erythritol Powder and Metronidazole Gel for the Non-surgical Treatment of Periodontitis

Role: lead

NCT01807416Phase 4Completed

Bone Dimensional Changes at Different Implant-to-abutment Connections: a 1-year Clinical and Radiological Study

Role: lead

NCT01800149Phase 4Completed

Healing of Post-ext Sites Using Bovine Bone Mineral: a CBCT and Histologic RCCT

Role: lead

NCT02023853Phase 4Completed

Non Surgical Treatment of Periimplantitis

Role: lead

NCT01821092Phase 4Completed

Dimensional Changes of Peri-implant Facial Bone

Role: lead

All 6 trials loaded